Ovarian Cancer Treatments
Find Ovarian Cancer Treatments
Medications for Ovarian Cancer
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Ovarian Cancer.
Found 10 Approved Drugs for Ovarian Cancer
Doxil
Generic Name
DOXOrubicin
Doxil
Generic Name
DOXOrubicin
Form: Injection, Injectable
Method of administration: Intravenous, Intravitreal
FDA approval date: May 01, 1996
Classification: Anthracycline Topoisomerase Inhibitor
Doxil liposomal infusion is an anthracycline topoisomerase inhibitor indicated for: Ovarian cancer: After failure of platinum-based chemotherapy.
Bevacizumab
Brand Names
Alymsys, Avastin, Avzivi, Avzivi tnjn, Jobevne, MVASI, Vegzelma, Zirabev
Bevacizumab
Brand Names
Alymsys, Avastin, Avzivi, Avzivi tnjn, Jobevne, MVASI, Vegzelma, Zirabev
Form: Injection
Method of administration: Intravenous, Intravascular
FDA approval date: February 26, 2004
Classification: Vascular Endothelial Growth Factor Inhibitor
Alymsys is a vascular endothelial growth factor inhibitor indicated for the treatment of: Metastatic colorectal cancer, in combination with intravenous fluorouracil-based chemotherapy for first- or second-line treatment.
Gemcitabine
Brand Names
Avgemsi, Inlexzo
Gemcitabine
Brand Names
Avgemsi, Inlexzo
Form: Injection, System
Method of administration: Intravenous, Intravesical
FDA approval date: November 15, 2010
Classification: Nucleoside Metabolic Inhibitor
AVGEMSI is a nucleoside metabolic inhibitor indicated: in combination with carboplatin, for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy.
Hycamtin
Generic Name
Topotecan
Hycamtin
Generic Name
Topotecan
Form: Injection, Capsule
Method of administration: Oral, Intravenous
FDA approval date: November 30, 2010
Classification: Topoisomerase Inhibitor
HYCAMTIN ® capsules are indicated for the treatment of relapsed small cell lung cancer (SCLC) in patients with a prior complete or partial response and who are at least 45 days from the end of first-line chemotherapy. HYCAMTIN capsules is a topoisomerase inhibitor indicated for treatment of patients with relapsed small cell lung cancer (SCLC). ( 1 )
Showing 1-5 of 10
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances